Literature DB >> 5534114

Studies on drug resistance. II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.

D Drahovsky, W Kreis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5534114     DOI: 10.1016/0006-2952(70)90259-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.

Authors:  J C White; J P Rathmell; R L Capizzi
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Authors:  K Bhalla; S Grant
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.

Authors:  Ajay Abraham; Savitha Varatharajan; Sreeja Karathedath; Chepsy Philip; Kavitha M Lakshmi; Ashok Kumar Jayavelu; Ezhilpavai Mohanan; Nancy Beryl Janet; Vivi M Srivastava; Ramachandran V Shaji; Wei Zhang; Aby Abraham; Auro Viswabandya; Biju George; Mammen Chandy; Alok Srivastava; Vikram Mathews; Poonkuzhali Balasubramanian
Journal:  Pharmacogenomics       Date:  2015-06-17       Impact factor: 2.533

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.